Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients

Objective To quantify more reliably the benefits and risks of monoamine oxidase type B inhibitors (MAOBIs) in early Parkinson's disease. Data sources Searches of the Cochrane Library, Medline, Embase, PubMed, and Web of Science for years 1966-2003, plus major journals in the field, abstract boo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ives, Natalie J, Stowe, Rebecca L, Marro, Joanna, Counsell, Carl, Macleod, Angus, Clarke, Carl E, Gray, Richard, Wheatley, Keith
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group Ltd. 2004
Aiheet:
Papers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC516655/
https://ncbi.nlm.nih.gov/pubmed/15310558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.38184.606169.AE
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia